Join to View Full Profile
4525 Sw 97th TerGainesville, FL 32608
Phone+1 352-372-3212
Dr. Chulay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumFellowship, Infectious Disease, 1976 - 1977
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1970 - 1974
Northwestern University The Feinberg School of MedicineClass of 1970
Certifications & Licensure
NC State Medical License 1995 - 2018
Publications & Presentations
PubMed
- 27 citationsIntravitreal Delivery of rAAV2tYF-CB-hRS1 Vector for Gene Augmentation Therapy in Patients with X-Linked Retinoschisis: 1-Year Clinical Results.Mark Edward Pennesi, Paul Yang, David G Birch, Christina Y Weng, Anthony T Moore
Ophthalmology. Retina. 2022-12-01 - 17 citationsDose Range Finding Studies with Two RPGR Transgenes in a Canine Model of X-Linked Retinitis Pigmentosa Treated with Subretinal Gene Therapy.Chunjuan Song, Valerie L. Dufour, Artur V. Cideciyan, Guo-jie Ye, Malgorzata Swider
Human Gene Therapy. 2020-07-15 - 22 citationsToxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized RPGR Delivered by Subretinal Injection in a Canine Model of X-linked Re...Valerie L. Dufour, Artur V. Cideciyan, Guo-jie Ye, Chunjuan Song, Adrian M. Timmers
Human Gene Therapy. 2020-02-14
Press Mentions
AGTC Appoints Matthew Feinsod, M.D. As Interim Chief Medical OfficerSeptember 5th, 2017
Grant Support
- Phase 2 Study Of Raav1-Cb-Haat For Treatment Of Alpha-1 Antitrypsin DeficiencyFood And Drug Administration2010–2011
- Phase 1/2 Trial Of Raav2-Cb-Hrpe65 (Bb-Ind 13848, 11 SEP 2009) For Leber CongenitFood And Drug Administration2010–2011
- Raav5-Hcngb3 Gene Therapy For Achromatopsia: Efficacy In A Dog ModelNational Eye Institute2010
- Alphavirus Replicon Vaccines Against Botulinum Neurotox*National Institute Of Allergy And Infectious Diseases2003–2006
- HIV Subtype C Alphavirus Vaccine Design &DevelopmentNational Institute Of Allergy And Infectious Diseases2002–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
